ZYLö THERAPEUTICS
Zylö Therapeutics offers an innovative sustained-release drug-delivery system that was developed by Joel Friedman MD PhD, Adam Friedman MD FAAD, and Andrew Draganski PhD. The delivery system uses patented hydrogel-derived nanoparticles, called Nanopods, to deliver—in a sustained and controlled manner—notoriously hard-to-deliver therapeutic agents through topical administration. The company was founded in 2017 and is based in Greenville, South Carolina.
ZYLö THERAPEUTICS
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2017-11-01
Address:
Greenville, South Carolina, United States
Country:
United States
Website Url:
http://www.zylotherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
858.775.6710
Email Addresses:
[email protected]
Total Funding:
13.49 M USD
Technology used in webpage:
Google Google Cloud COVID-19 Wix
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
Lifescient, Inc.
Therapeutics and Drug Delivery Systems
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
NIAMS
NIAMS investment in Grant - Zylö Therapeutics
New York Angels
New York Angels investment in Series B - Zylö Therapeutics
James Cordes
James Cordes investment in Series B - Zylö Therapeutics
Harvard Business School Alumni Angels of Greater NY
Harvard Business School Alumni Angels of Greater NY investment in Series B - Zylö Therapeutics
Cowtown Angels
Cowtown Angels investment in Series B - Zylö Therapeutics
SC Launch, Inc.
SC Launch, Inc. investment in Series B - Zylö Therapeutics
Boston Harbor Angels
Boston Harbor Angels investment in Series B - Zylö Therapeutics
VentureSouth
VentureSouth investment in Series B - Zylö Therapeutics
SC Launch, Inc.
SC Launch, Inc. investment in Grant - Zylö Therapeutics
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Diabetes and Digestive and Kidney Diseases investment in Grant - Zylö Therapeutics
Official Site Inspections
http://www.zylotherapeutics.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Zylö Therapeutics"
About | Zylö Therapeutics
©2019-2023 Powered by Z-pods® and by Zylö Therapeutics. bottom of pageSee details»
Zylö Therapeutics - Crunchbase Company Profile & Funding
Zylö Therapeutics offers an innovative sustained-release drug-delivery system. View contacts for Zylö Therapeutics to access new leads and connect with decision-makers.See details»
Zylö Therapeutic, Inc. - Drug pipelines, Patents, Clinical trials
May 1, 2024 For more details, please visit our website, www.zylotherapeutics.com, and follow us on Twitter (@ZyloTherapies). For questions, please contact: Scott R. PancoastCEO + …See details»
Contact | Zylö Therapeutics
We’re happy to hear from you. Contact us to learn more about our business and how you might be able to get Powered by Z-pods®See details»
Zylö Therapeutics | Greenville, SC, USA Startup - Gust
Website zylotherapeutics.com; Company Summary The Z-pod delivery system is versatile, affordable & 'next-generation, with countless applications' (source: a leading MD who heads …See details»
Zylö Therapeutics Closes $4 Million Series A Financing - SCbio
Sep 26, 2019 For more details please visit our web site, www.zylotherapeutics.com and follow us on Twitter (@ZyloTherapies). ... SCbio is South Carolina’s investor-driven economic …See details»
Zylo Therapeutics | CipherBio
Explore Zylo Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Silo Pharma (SILO) and Zylo Therapeutics, Inc. (ZTI) enter into Joint ...
Apr 28, 2021 www.zylotherapeutics.com. About Silo Pharma Silo Pharma. Inc. is a developmental stage biopharmaceutical company focused on merging traditional therapeutics …See details»
Zylö Therapeutics Closes $5.225 Million Series B Financing
Jun 3, 2022 For more details, please visit our website, www.zylotherapeutics.com, and follow us on Twitter (@ZyloTherapies). Scott R. Pancoast, CEO + founder (858) 775-6710: …See details»
Zylö Therapeutics - Greenville, South Carolina, United States ...
Solving bioavailability, solubility, targeting, and stability challenges for cosmetic, OTC, and biopharma market segments. Zylö also plans to launch its own branded line in early 2025. · …See details»
Awards | Zylö Therapeutics
2023: Finalist of InnoVision’s 2023 competition for top technology applications in South Carolina—winner to be announced in October 2023. (InnoVision Awards is South Carolina’s …See details»
Zylo Therapeutics Company Profile -Sales, Contacts, Competitors – …
Zylo Therapeutics is in the Pharmaceutical Preparations industry within the Chemicals and Allied Products sector and has been in business for approximately 7 years.See details»
Zylo Therapeutics (USA) Funding: $13.5M - Medical Startups
Nov 26, 2024 Zylö Therapeutics has an innovative sustained-release drug-delivery system that uses patented hydrogel-derived...See details»
Zylö Therapeutics Closes $5.225 Million Series B Financing
GREENVILLE, SC, June 03, 2022 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., dedicated to developing a transformational drug-delivery platform, announced that it has raised $5.225 …See details»
Partners | Zylö Therapeutics
To discuss our delivery platform in more detail and explore potential business development opportunities, please contact us using the form below or contact us directly: …See details»
Zylö Therapeutics locating new operations in Greenville County, …
Jan 11, 2018 GREENVILLE, S.C. – Zylö Therapeutics, a developer of state-of-the-art technology for the pharmaceutical industry, is locating new operations inSee details»
Zylö Receives $600,000 NIH Phase I Grant to Develop a Novel …
Aug 19, 2022 Zylö Therapeutics Inc., developer of the Z-pod® topical delivery platform, has been awarded a two-year $600,000 Small Business Innovation Research (SBIR)See details»
Powered by Z-pods - Zylö Auto
Zylö’s Z-pods® are highly engineered amorphous silica particles designed to encapsulate compounds and improve product performance in a wide range of market segments.See details»
Powered by Z-pods | Zylö Therapeutics
Zylö’s technology has overcome the bioavailability limitations of AEA, an endocannabinoid: AEA-loaded Z-pods® demonstrated significant reduction in lesion count and severity in a lupus …See details»